MCP-1/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis

Chaoyang Sun, Xi Li, Ensong Guo, Na Li, Bo Zhou, Hao Lu, Jia Huang, Meng Xia, Wanying Shan, Beibei Wang, Kezhen Li, Danhui Weng, Xiaoyan Xu, Qinglei Gao, Shixuan Wang, Junbo Hu, Yiling Lu, Gordon B. Mills, Gang Chen

Research output: Contribution to journalArticlepeer-review

43 Scopus citations


Ovarian cancer selective metastasizes to the omentum contributing to the poor prognosis associated with ovarian cancer. However, the mechanism underlining this propensity and therapeutic approaches to counter this process has not been fully elucidated. Here, we show that MCP-1 produced by omental adipocytes binding to its cognate receptor CCR-2 on ovarian cancer cells facilitates migration and omental metastasis by activating the PI3K/AKT/mTOR pathway and its downstream effectors HIF-1α and VEGF-A in cell lines, xenografts, and transgenic murine models. MCP-1 antibody significantly decreased tumor burden and increased survival of mice in vivo. Interestingly, metformin decreased omental metastasis at least partially by inhibiting MCP-1 secretion from adipocytes independent of direct effects on cancer cells. Together this suggests a novel target of MCP-1/CCR-2 axis that could benefit ovarian cancer patients.

Original languageEnglish (US)
Pages (from-to)1681-1695
Number of pages15
Issue number8
StatePublished - Feb 20 2020
Externally publishedYes

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research


Dive into the research topics of 'MCP-1/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis'. Together they form a unique fingerprint.

Cite this